MANGALAM DRUG A VALUE BUY

WHEN MANGALAM DRUG SALES WAS AROUND 200 CR ITS PRICE WAS 400 PLUS NOW IN LAST 2 YEARS SALES GROWTH UP BY 40% WHILE PRICE GROWTH DOWN BY 36% WITH NEGATIVE RETURN. EPS GROWTH IN 2 YEARS AROUND 200% BUT DUE TO PHARMA SECTOR DOWN TREND PRICE WENT DOWN BUT AFTER THIS MANGALAM HAS DONE … Continue reading MANGALAM DRUG A VALUE BUY